Volume 143, Issue 4, Pages (October 2012)

Slides:



Advertisements
Similar presentations
Volume 141, Issue 2, Pages e2 (August 2011)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 138, Issue 1, Pages (January 2010)
Volume 134, Issue 7, Pages (June 2008)
Volume 132, Issue 2, Pages (February 2007)
Volume 137, Issue 3, Pages (September 2009)
Volume 133, Issue 5, Pages (November 2007)
CD271 on Melanoma Cell Is an IFN-γ-Inducible Immunosuppressive Factor that Mediates Downregulation of Melanoma Antigens  Junpei Furuta, Takashi Inozume,
Volume 136, Issue 4, Pages e3 (April 2009)
Tatsukuni Ohno, Yuta Kondo, Chenyang Zhang, Siwen Kang, Miyuki Azuma 
Volume 136, Issue 3, Pages (March 2009)
Dissolving Microneedle Delivery of Nanoparticle-Encapsulated Antigen Elicits Efficient Cross-Priming and Th1 Immune Responses by Murine Langerhans Cells 
Volume 130, Issue 2, Pages (February 2006)
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Volume 130, Issue 2, Pages (February 2006)
Effects and Regulation of Autoreactive CD8+ T Cells in a Transgenic Mouse Model of Autoimmune Hepatitis  Mario Zierden, Elisabeth Kühnen, Margarete Odenthal,
Volume 137, Issue 4, Pages e5 (October 2009)
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor  Eran Elinav, Nitzan Adam,
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 132, Issue 7, Pages (June 2007)
Volume 141, Issue 4, Pages e1 (October 2011)
Α-MSH-Stimulated Tolerogenic Dendritic Cells Induce Functional Regulatory T Cells and Ameliorate Ongoing Skin Inflammation  Matteo Auriemma, Thomas Brzoska,
Volume 137, Issue 3, Pages (September 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 140, Issue 7, Pages (June 2011)
Volume 35, Issue 6, Pages (December 2011)
Norito Katoh, Fujiko Soga, Takeshi Nara, Koji Masuda, Saburo Kishimoto 
Volume 135, Issue 3, Pages (September 2008)
Volume 141, Issue 5, Pages (November 2011)
Volume 137, Issue 5, Pages (November 2009)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 13, Issue 1, Pages (January 2006)
Volume 134, Issue 7, Pages (June 2008)
Volume 18, Issue 3, Pages (March 2003)
Volume 27, Issue 2, Pages (August 2007)
Volume 25, Issue 1, Pages (January 2014)
Volume 17, Issue 8, Pages (August 2009)
Volume 29, Issue 5, Pages (November 2008)
Volume 135, Issue 1, Pages (July 2008)
Volume 13, Issue 12, Pages (December 2015)
Volume 135, Issue 5, Pages e5 (November 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Role of B cells in TH cell responses in a mouse model of asthma
Volume 29, Issue 6, Pages (December 2008)
Volume 138, Issue 1, Pages (January 2010)
Volume 36, Issue 6, Pages (June 2012)
Volume 33, Issue 4, Pages (October 2010)
Volume 19, Issue 3, Pages (September 2003)
Fetal Calf Serum-Free Generation of Functionally Active Murine Dendritic Cells Suitable for In Vivo Therapeutic Approaches  Gabriele Müller, Anke Müller,
Volume 33, Issue 3, Pages (September 2010)
Volume 135, Issue 3, Pages (September 2008)
Volume 34, Issue 3, Pages (March 2011)
Ana Belén Blázquez, Lloyd Mayer, M. Cecilia Berin  Gastroenterology 
Volume 119, Issue 1, Pages (July 2000)
Volume 29, Issue 1, Pages (July 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Chie Kudo-Saito, Hiromi Shirako, Tadashi Takeuchi, Yutaka Kawakami 
Volume 26, Issue 4, Pages (April 2007)
Volume 131, Issue 6, Pages (December 2006)
Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand  Yelena Glinka,
Notch 1 Signaling Regulates Peripheral T Cell Activation
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 35, Issue 1, Pages (July 2011)
Interleukin-10-Treated Dendritic Cells Modulate Immune Responses of Naive and Sensitized T Cells In Vivo  Gabriele Müller, Anke Müller  Journal of Investigative.
Patrizia Stoitzner, Christoph H
Volume 19, Issue 4, Pages (October 2003)
Presentation transcript:

Volume 143, Issue 4, Pages 1061-1072 (October 2012) Dendritic Cell Populations With Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver  Junaid Ibrahim, Andrew H. Nguyen, Adeel Rehman, Atsuo Ochi, Mohsin Jamal, Christopher S. Graffeo, Justin R. Henning, Constantinos P. Zambirinis, Nina C. Fallon, Rocky Barilla, Sana Badar, Aaron Mitchell, Raghavendra S. Rao, Devrim Acehan, Alan B. Frey, George Miller  Gastroenterology  Volume 143, Issue 4, Pages 1061-1072 (October 2012) DOI: 10.1053/j.gastro.2012.06.003 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Distinct liver DC populations are defined by their endogenous lipid content. (A) Live murine liver NPCs were gated, and CD11c+ cells were analyzed for BODIPY staining. (B) Fluorescence-activated cell sorted (FACS) CD11c+MHCII+ high-DC and low-DC were spun onto slides and assessed by HCS LipidTOX Red neutral lipid staining. (C) Human liver NPCs were costained using BODIPY and antibodies reactive with HLA-DR and lineage markers. (D and E) Murine high-DC and low-DC were purified by FACS and tested for expression of (D) C/EBPα, lipoprotein lipase, and PPAR-γ by polymerase chain reaction (***P < .001) and (E) for expression of GRP78 (BiP), peIF2α, eIF2α, and β-actin by Western blotting. (F) Representative purified high-DC and low-DC were stained with H&E and compared with CD11c+MHCII+ spleen DCs or bone marrow–derived DCs. Gastroenterology 2012 143, 1061-1072DOI: (10.1053/j.gastro.2012.06.003) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 High-DC exhibits an immunogenic phenotype. (A) High-DC and low-DC were analyzed for expression of surface markers. Median fluorescence index for high-DC and low-DC is indicated below the respective histograms. (B) Liver and spleen DC production of cytokines and chemokines was measured in cell culture supernatants. (C) Liver DC populations were also assessed by intracellular cytokine staining for production of IL-17α and TNF-α. (D) High-DC and low-DC were isolated from the human liver by FACS and cultured alone or with lipopolysaccharide before analysis of cytokines in cell culture supernatant. (E) Mouse liver DC production of IL-6 and TNF-α was measured in cell culture supernatant after selective TLR ligation. (F) TLR expression in high-DC and low-DC was determined by flow cytometry. Experiments were repeated 3–4 times using 3 mice per group (*P < .05; **P < .01; ***P < .001). Gastroenterology 2012 143, 1061-1072DOI: (10.1053/j.gastro.2012.06.003) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 High-DC potently activates CD4+ T cells, whereas low-DC generates Tregs. (A) CD4+OT-II cellular proliferation, (B) surface phenotype, and (C) cytokine production were measured after coculture with high-DC or low-DC loaded with Ova323–339 peptide or culture with peptide-pulsed spleen DCs. (D) CD4+OT-II T-cell proliferation was also measured in vivo in the draining popliteal lymph node after footpad immunization with saline or antigen-loaded high-DC or low-DC. The fraction and total number of proliferating CD4+ T cells is shown. (E) After 5 days of DC coculture with allogeneic CD4+ T cells, CD4+CD25+ cells were gated and analyzed for coexpression of Foxp3. The fraction and total number of CD25+Foxp3+ cells is shown. Experiments were performed in triplicate and repeated 3 times (*P < .05; **P < .01; ***P < .001). Gastroenterology 2012 143, 1061-1072DOI: (10.1053/j.gastro.2012.06.003) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 High-DC generates potent de novo CTL, enhances preexisting CTL, and mediates tumor protection. (A) Lysis of Ova-expressing targets in the liver and spleen was measured in mice twice immunized with high-DC or low-DC Ova257–264. (B) Similarly, the fraction of Ova-tetramer–positive T cells among all CD8+ T cells was measured in the liver of mice immunized using peptide-pulsed high-DC, low-DC, or bulk spleen DCs. (C) Cytokines were measured in day 4 spleen CTL cultures that were restimulated with Ova257–264 peptide. (D) CTL lysis of Ova-expressing targets in the spleen as well as (E) IL-2 and IL-10 production in spleen CTL cultures were measured in Rag1 mice that had been reconstituted with OT-I T cells and then immunized with either high-DC or low-DC Ova257–264. Experimental results were reproduced at least 3 times (*P < .05; **P < .01; ***P < .001). (F) Mice were challenged with EG7 after immunization with saline or high-DC or low-DC or bulk spleen DCs loaded with Ova257–264 peptide. Time to tumor development (P < .01 for comparison between high-DC and low-DC) and mean tumor size at 21 days are shown (mean n = 6/group). Gastroenterology 2012 143, 1061-1072DOI: (10.1053/j.gastro.2012.06.003) Copyright © 2012 AGA Institute Terms and Conditions

Figure 5 Low-DC is poor at capturing antigen and mediating intrahepatic tolerance. (A) Hepatic DC fluorescence was measured 1 hour after feeding mice ovalbumin conjugated to antigen-presenting cells. Median fluorescence indexes are indicated. (B) High-DC and low-DC uptake of ovalbumin and mannosylated albumin was measured in vitro at various time points and (C) in vivo at 1 hour after intraperitoneal administration of the respective fluorescent antigens. Restimulated spleen cultures from mice that received adoptively transferred high-DC or low-DC from ovalbumin-fed or sham-fed donors were interrogated for production of (D) IL-2 and (E) IL-10. (F) The number of intrahepatic Ova tetramer-positive cells was measured at 96 hours in mice treated with OT-I T cells followed by injection of saline, ovalbumin, or ovalbumin and C75. Experiments were repeated at least 3 times (n = 3–5 mice per group; *P < .05; **P < .01; ***P < .001). Gastroenterology 2012 143, 1061-1072DOI: (10.1053/j.gastro.2012.06.003) Copyright © 2012 AGA Institute Terms and Conditions

Figure 6 High-DC activates innate immunity whereas low-DC induces anergy. (A and B) Liver high-DC and low-DC and spleen DCs were cocultured with NK cells and interrogated for production of (A) IL-6 and IFN-γ. (B) NK1.1+ cells were gated and analyzed for expression of CD69 on flow cytometry. (C and D) Liver DC-iNKT cell cocultures were interrogated for production of (C) IL-6, IFN-γ, and TNF-α. (D) In addition, iNKT cells were gated and analyzed for expression of CD25. (E) High-DC and low-DC were analyzed for expression of Notch1, Jagged1, and Delta4 by flow cytometry. (F) High-DC and low-DC were also analyzed for expression of Jagged1, Delta4, and β-actin by Western blotting (**P < .01; ***P < .001). Gastroenterology 2012 143, 1061-1072DOI: (10.1053/j.gastro.2012.06.003) Copyright © 2012 AGA Institute Terms and Conditions

Figure 7 High-DC immunogenicity is abrogated by blocking TNF-α or lessening ER stress. (A) CD4+OT-II T cells were cultured alone or cocultured with high- or low-DC Ova323–339 in the presence or absence of a monoclonal antibody against TNF-α. IFN-γ was measured in cell culture supernatant. (B and C) Similarly, DC-NK cocultures were performed in the presence of TNF-α blockade before measuring (B) IFN-γ and (C) IL-6. (D) Peptide-pulsed high-DC, alone or with chaperone, was used to stimulate OT-II T cells. TNF-α was measured in cell culture supernatant. Experiments were repeated 2–3 times (*P < .05; **P < .01; ***P < .001). Gastroenterology 2012 143, 1061-1072DOI: (10.1053/j.gastro.2012.06.003) Copyright © 2012 AGA Institute Terms and Conditions